Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jean L. Grem, MD
University of Nebraska
Study Chair - Neal J. Meropol, MD
Fox Chase Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
110 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- California Cancer Care, Incorporated - Greenbrae
Greenbrae, California, United States
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Ccop - Colorado Cancer Research Program
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- St. Anthony Central Hospital
Denver, Colorado, United States
- St. Joseph Hospital
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- St. Mary'S Regional Cancer Center at St. Mary'S Hospital and Medical Center
Grand Junction, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- Littleton Adventist Hospital
Littleton, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
- Mckee Medical Center
Loveland, Colorado, United States
- Parker Adventist Hospital
Parker, Colorado, United States
- St. Mary - Corwin Regional Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thornton, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- University of Florida Shands Cancer Center
Gainesville, Florida, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Veterans Affairs Medical Center - Atlanta (decatur)
Decatur, Georgia, United States
- Hematology and Oncology Associates
Chicago, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Saint Joseph Hospital
Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- Provena St. Mary'S Regional Cancer Center - Kankakee
Kankakee, Illinois, United States
- North Shore Oncology and Hematology Associates, Limited - Libertyville
Libertyville, Illinois, United States
- Cancer Care and Hematology Specialists of Chicagoland - Niles
Niles, Illinois, United States
- Swedish-American Regional Cancer Center
Rockford, Illinois, United States
- Hematology Oncology Associates - Skokie
Skokie, Illinois, United States
- Elkhart General Hospital
Elkhart, Indiana, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Veterans Affairs Medical Center - Indianapolis
Indianapolis, Indiana, United States
- William N. Wishard Memorial Hospital
Indianapolis, Indiana, United States
- Howard Community Hospital
Kokomo, Indiana, United States
- Center for Cancer Therapy at Laporte Hospital and Health Services
La Porte, Indiana, United States
- Saint Joseph Regional Medical Center
Mishawaka, Indiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Sept 2005
- Primary completion
- 30 Nov 2013
- Completion
- 30 Apr 2015
- Last update posted
- 5 Jul 2023
- Registered enrollment
- 247
- Registry id
- NCT00098787
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.